Receipt of methadone for opioid use disorder is associated with a lower risk for treatment discontinuation compared with buprenorphine/naloxone, according to a study published online Oct. 17 in JAMA.

People with opioid use disorder in British Columbia who received methadone had a 37–40 per cent lower rate of treatment discontinuation compared with those who received buprenorphine/naloxone. The new ...

Forbes contributors publish independent expert analyses and insights. I write about issues at the intersection of medicine and culture. Now comes a provocative new study by economists Jennifer Doleac ...

Patients with opioid use disorder (OUD) had a lower risk of discontinuing methadone compared with buprenorphine/naloxone, and with a similar mortality risk, according to a population-based cohort ...

About The Study: Individuals receiving methadone had a lower risk of treatment discontinuation compared with those who received buprenorphine/naloxone. The risk of mortality while receiving treatment ...

Methadone showed lower treatment discontinuation risk than buprenorphine/naloxone in OUD patients, with longer median treatment duration. Current international guidelines for opioid agonist treatment ...

Around 1% of Australian adults have tried heroin in their lifetime and 2.7% have used pharmaceutical opioids for non-medical purposes in the past 12 months. These drugs attach to the opioid receptors ...

Opioid prescribing rates vary drastically by region Research has shown that use of suboxone and methadone, in conjunction with counseling, can be effective addiction treatment. I have recently ...

AVENTURA, Florida — Data from a phase IV hepatic safety study show no evidence of liver toxicity from buprenorphine/naloxone and methadone. In the multicenter 24-week study of 731 patients in mild to ...

Please provide your email address to receive an email when new articles are posted on . Women receiving buprenorphine-naloxone therapy for the treatment of opioid use disorder during pregnancy had ...

Buprenorphine combined with naloxone during pregnancy is associated with lower risks for neonatal abstinence syndrome and neonatal intensive care unit admission than buprenorphine alone. The study ...

Risk for mortality while receiving treatment was similar between medications. HealthDay News — Receipt of methadone for opioid use disorder is associated with a lower risk for treatment ...